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humans, environmental samples and, more recently, companion
animals [1]. Among the newly emerged carbapenemases, New
Delhi metallo-β-lactamase (NDM) represents the latest threat
for public health [2]. Sixteen variants of NDM-type carbape-
nemase (NDM-1 to NDM-16) have been reported (http://www.
lahey.org/Studies).
Here we report what is to our knowledge the ﬁrst case of
Escherichia coli carrying the blaNDM-5 gene isolated from a dog in
Algeria.
In March 2015 a rectal swab was collected from a 3-year-old
German Shepherd dog with a tumor at its third ﬁnger. The
sample was cultured in 10 mL nutrient broth containing half a
disc of ertapenem. After incubation at 37°C for 24 hours, 200
μL was streaked on MacConkey agar plates containing imipe-
nem at a concentration of 0.5 μg/mL. An Escherichia coli isolate
was identiﬁed by MALDI-TOF (matrix-assisted laser desorp-
tion/ionization time-of-ﬂight mass spectrometry; Microﬂex,
Bruker Daltonics, Bremen, Germany). Antibiotic susceptibility
testing was performed by the disk diffusion method and inter-
preted according to the European Committee on Antimicrobial
Susceptibility Testing guidelines (http://www.eucast.org/). The
minimum inhibitory concentration (MIC) values of β-lactams
were determined using Etest strips according to the manufac-
turer’s recommendations (AB bioMérieux, Solna, Sweden).New Microbes and New Infections © 2015 The Authors. Published by El
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carbapenems (MICs >32 μg/mL) and extended-spectrum
cephalosporins (MICs >256 μg/mL). The isolate was also
resistant to tetracycline and ﬂuoroquinolones but was suscep-
tible to amikacin, cotrimoxazole, colistin and tigecycline.
The isolate was screened for carbapenemase production
using the modiﬁed Carba NP test [3], and the production of
metallo-β-lactamases was detected by the inhibition of the
metallo-β-lactamase activity by ethylenediaminetetraacetic acid
(EDTA) as previously described [4]. The E. coli isolate was
positive for production of carbapenemase, which is inhibited by
EDTA.
PCR was used to screen for the presence of genes encoding
for class A carbapenemases (blaKPC and blaGES), class D car-
bapenemases (blaOXA-48) and metallo-β-lactamases (blaNDM-1
and blaVIM) as previously described [5], followed by sequencing,
which led to the identiﬁcation of blaNDM-5. A review the liter-
ature at PubMed found 12 reports on NDM-5, which were all
recovered from clinical specimens; no reports were from vet-
erinary isolates, however. Among these 12 reports, one was
from Algeria [6]. The authors of this study reported three
isolates of E. coli sequence type (ST) 2659 recovered from urine
and blood specimen isolated between January 2012 and
February 2013 in the university hospital of Annaba (east
Algeria). Thus, this is the ﬁrst report of NDM-5-producing
E. coli isolated from companion animals. Furthermore, other
types of carbapenemases have been reported from domesti-
cated animals, including NDM-1 in multidrug-resistant E. coli
strains recovered from companion animals in the United States
[7], and OXA-48 carbapenemase-producing Klebsiella pneumo-
niae and E. coli isolates obtained from a dog in Germany [8]. The
E. coli isolate also carried the blaTEM-33 gene.
The transferability of the resistance phenotype was studied
by a conjugation experiment using sodium azide–resistant E. coli
strain J53 as a recipient. The transconjugants were selected on
Luria agar plates containing ceftazidime (8 μg/mL) and sodium
azide (200 μg/mL) [2]. Only transconjugants carrying the bla-
TEM-33 gene were obtained. To determine the localization of the blaNDM-5
gene the isolate was subjected to plasmid extraction using the
High Purity Plasmid Miniprep Kit (Neobiotech, Los Angeles,
CA, USA) and the QIAquick Gel extraction kit (Qiagen, Ger-
mantown, MD, USA), followed by PCR ampliﬁcation targeting
blaNDM-5 performed on the extracted plasmid. The result
showed that the isolate harboured only one plasmid which did
not contain the blaNDM-5 gene, indicating that this gene is
probably integrated into the chromosome.
Genotyping of the isolate was performed by multilocus
sequence typing (MLST) using seven housekeeping genes (adk,
fumC, gyrB, icd, mdh, purA and recA), as described at the E. coliNew Microbe and New Infect 2015; 8: 17–18
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cording to MLST analysis, the E. coli isolate was attributed to
ST1284. This ST has been identiﬁed previously in E. coli isolates
producing extended-spectrum β-lactamase recovered from
animals [9].
In summary, this report documents the emergence of NDM-
5 among E. coli ST1284 isolated for the ﬁrst time from a
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